Aptose Biosciences (APTO) to Offer Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- Japan has no plans to overhaul pension funds' asset allocation, sources say
Aptose Biosciences (APTO) Prices 10.5M Share Common Offering at $5.25/Sh
July 16, 2020 6:04 AM EDTAptose Biosciences Inc. (NASDAQ: APTO) today announced that it priced its previously announced underwritten public offering of 10,500,000 common shares (the Offering) at a public offering price of US$5.25 per share. Gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses... More
